ATX-304 - Cambrian Biopharma
https://www.abstractsonline.com/pp8/#!/20942/presentation/5387
 
Erik J. Schneider, BA 1 ,2; James A. Hall, MD, PhD 1; Gizem Bor, PhD 3; David Jacobs, MD, MBA 1; Ruth Thieroff-Ekerdt, MD 1 ,2
 
Apr 27, 2025
 
Next